It would appear that David will be pushing amarantus' interest in Europe while GC focuses on North America. In essence, david will be a co-CEO. If anything it helps us. David is the seasoned pharma exec and has connections on that continent.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.